Pulmatrix, Inc.  announced that it has entered into a research collaboration with Nocion Therapeutics to explore new technologies to enable and improve inhaled drug delivery.  The collaboration will leverage Pulmatrix's iSPERSE platform and expertise in seeking to transform promising assets to improve drug delivery and safety profiles.